StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc. (GILD) operating KPIs

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)

Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%

Gilead Sciences unrecognized tax benefits that, if recognized, would affect the effective tax rate ($M) ($M)

Form 10-K Note 15

Latest, FY2025
900
Period ended Dec 31, 2025
Change on a year earlier
-35.7%
1,400 in FY2024
History
12 years
Since FY2014
Sources
10
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedUnrecognized tax benefits that, if recognized, would affect the effective tax rate ($M) ($M)Year on yearSource
FY2025Dec 31, 2025900-35.7%Form 10-K (filed 2026-02-24) ↗
FY2024Dec 31, 20241,400+50.7%Form 10-K (filed 2026-02-24) ↗
FY2023Dec 31, 2023929-1.8%Form 10-K (filed 2025-02-28) ↗
FY2022Dec 31, 2022946+18.3%Form 10-K (filed 2024-02-23) ↗
FY2021Dec 31, 2021800-33.3%Form 10-K (filed 2023-02-22) ↗
FY2020Dec 31, 20201,200-25.0%Form 10-K (filed 2022-02-23) ↗
FY2019Dec 31, 20191,600+23.1%Form 10-K (filed 2021-02-25) ↗
FY2018Dec 31, 20181,300-27.8%Form 10-K (filed 2019-02-26) ↗
FY2017Dec 31, 20171,8000.0%Form 10-K (filed 2019-02-26) ↗
FY2016Dec 31, 20161,800+38.5%Form 10-K (filed 2018-02-27) ↗
FY2015Dec 31, 20151,300+115.9%Form 10-K (filed 2017-02-27) ↗
FY2014Dec 31, 2014602–Form 10-K (filed 2016-02-24) ↗

Cite this data

StockData. (2026). Gilead Sciences Unrecognized tax benefits that, if recognized, would affect the effective tax rate ($M) ($M), annual FY2014–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/utb_etr_impact

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.